Author/Creator: Zhao, Y. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Zhao, Y.

1. 'Be water' strategy of liquid lithium sulfide enables 0.2 V potential barrier for high-performance lithium–sulfur batteries. (September 2021)

Authors:: Zhao, Y.; Zhang, Z.; Wu, R.; Lyu, C.; Zhao, X.; Xu, H.; Xiang, J.; Zha, C.; Ouyang, G.; Wang, L.
Journal:: Materials today energy
Issue:: Volume 21(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 'Candidatus Phytoplasma brasiliense'-related strains associated with papaya bunchy top disease in northern Peru represent a distinct geographic lineage. (February 2017)

Authors:: Wei, W.; Pérez-López, E.; Davis, R.E.; Bermúdez-Díaz, L.; Granda-Wong, C.; Wang, J.; Zhao, Y.
Journal:: Crop protection
Issue:: Volume 92(2017)
Page Start:: 99
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. 000221 PROGESTERONE RECEPTOR-B GENE REACTIVATION IN POORLY DIFFERENTIATED ENDOMETRIAL CANCER CELLS BY EPIGENETIC MODIFICATION REAGENTS. (1st September 2005)

Authors:: Dowdy, S. C; Xiong, Y.; Gonzalez, J.; Zhao, Y.; Eberhardt, N. L.; Podratz, K. C.; Jiang, S.
Journal:: International journal of gynecological cancer
Issue:: Volume 15(2005)Supplement 2
Page Start:: 112
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. 104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022)

Authors:: Zhao, Y.; Wang, X.; Zhang, M.; Liu, J.; Pu, H.; Li, X.; Zhao, H.; Xu, S.; Yang, M.; Bai, S.; Guo, L.; Zhao, L.; Li, Y.; Wang, Y.
Journal:: Immuno-oncology technology
Issue:: Volume 16(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. 1064‐nm Q‐switched Nd:YAG laser is an effective and safe approach to treat xanthelasma palpebrarum in Asian population. (9th June 2014)

Authors:: Zhao, Y.; Wen, C.M.; Zhou, N.N.; Feng, Q.; Tu, P.
Journal:: Journal of the European Academy of Dermatology and Venereology
Issue:: Volume 29:Number 11(2015:Nov.)
Page Start:: 2263
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. 136P Tislelizumab (TIS) plus chemotherapy (chemo) for EGFR-mutated non-squamous non-small cell lung cancer (nsq-NSCLC) failed to EGFR tyrosine kinase inhibitors (TKIs) therapies: The primary analysis. (December 2022)

Authors:: Han, B.; Zhong, H.; Tian, P.; Zhao, Y.; Guo, Q.; Yu, X.; Yu, Z.; Zhang, X.; Li, Y.; Chen, L.; Zhang, Y.; Shi, X.; Wang, J.
Journal:: Immuno-oncology technology
Issue:: Volume 16(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. 141P Efficacy and safety of tislelizumab combined with targeted therapy as first-line treatment for unresectable hepatocellular carcinoma: A real-world study. (December 2022)

Authors:: Wang, L.; Zhao, Y.; Zhang, T.; Wang, L.
Journal:: Immuno-oncology technology
Issue:: Volume 16(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. 149P A phase Ⅰb/Ⅱ trial of surufatinib plus toripalimab and etoposide (E) combined with cisplatin (P) in patients (pts) with untreated advanced small cell lung cancer (SCLC). (December 2022)

Authors:: Fang, W.F.; Huang, Y.; Yang, Y.; Zhao, Y.; Zhang, Y.; Zhou, T.; Zhao, S.; Yuxiang, M.; Hong, S.D.; Zhao, H.; Zhang, L.
Journal:: Immuno-oncology technology
Issue:: Volume 16(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. 162P Efficacy and safety of GEMOX (gemcitabine plus oxaliplatin) plus sintilimab and bevacizumab as a conversion therapy in patients with initially unresectable biliary tract cancers (BTC): A single-arm, phase II study. (December 2022)

Authors:: Zhang, N.; Zhou, J.; Wang, L.; Zhang, T.; Zhu, W.; Mao, A.; Pan, Q.; Lin, Z.; Wang, M.; Zhang, Y.; Feng, Y.; Xu, W.; Zhao, Y.; Wang, L.
Journal:: Immuno-oncology technology
Issue:: Volume 16(2022)Supplement 1
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. 210 DECITABINE TREATMENT COULD AMELIORATE PRIMARY IRON-OVERLOAD IN MYELODYSPLASTIC SYNDROME PATIENTS. Issue 1 (April 2015)

Authors:: Chunkang, C.; Gu, S.; Zhao, Y.; Guo, J.; Fei, C.; Xv, F.; Xiao, C.; Li, X.
Journal:: Leukemia research
Issue:: Volume 39:Issue 1(2015:Jan.)
Page Start:: S105
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗